Viewing Study NCT00170820


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-02-09 @ 7:30 AM
Study NCT ID: NCT00170820
Status: COMPLETED
Last Update Posted: 2017-02-27
First Post: 2005-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal transplantation, maintenance, switch, everolimus, CNI-free View